Monkeypox: is it the time for autopsy?

Ir J Med Sci

Faculty of Medicine, University of Gezira, Wad Madani, Sudan.

Published: August 2023

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9592536PMC
http://dx.doi.org/10.1007/s11845-022-03200-wDOI Listing

Publication Analysis

Top Keywords

monkeypox time
4
time autopsy?
4
monkeypox
1
autopsy?
1

Similar Publications

Background: Tecovirimat, an antiviral treatment for smallpox, was approved as a treatment for mpox by the European Medicines Agency in January 2022. Approval was granted under "exceptional circumstances" based on effectiveness found in pre-clinical challenge studies in animals and safety studies in humans showing minimal side effects. As clinical efficacy studies are still ongoing, there is currently limited information with regard to the acceptability of tecovirimat to treat mpox.

View Article and Find Full Text PDF

Background: Monkeypox has emerged as a global health concern, necessitating preventive measures and awareness among healthcare students. Understanding nursing students' fears, concerns, and preventive practices regarding Monkeypox can help improve preparedness and response strategies.

Aim: This study aimed to assess the levels of fear, concerns, and preventive practices related to monkeypox among nursing students at Beni Suef University, Egypt, during the 2024-2025 academic year.

View Article and Find Full Text PDF
Article Synopsis
  • Monkeypox (MPOX) is caused by the Orthopoxvirus monkeypox (MPXV) and presents symptoms akin to smallpox, with ongoing outbreaks raising global public health concerns, especially in the Democratic Republic of the Congo and recently in China.
  • A new lineage of MPXV (C.1.1) was identified from samples in a Nantong outbreak, possibly linked to cases imported from Japan.
  • Genomic analysis revealed reduced mutations in MPXV and specific mutations in proteins that could affect its evolution and vaccine development, indicating potential research directions for understanding the virus.
View Article and Find Full Text PDF

In the context of the global damage caused by coronavirus disease 2019 (COVID-19) and the emergence of the monkeypox virus (MPXV) outbreak as a public health emergency of international concern, research into methods that can rapidly test potential therapeutics during an outbreak of a new infectious disease is urgently needed. Computational drug discovery is an effective way to solve such problems. The existence of various large open databases has mitigated the time and resource consumption of traditional drug development and improved the speed of drug discovery.

View Article and Find Full Text PDF

Monkeypox: A comprehensive review on mutation, transmission, pathophysiology, and therapeutics.

Int Immunopharmacol

January 2025

School of Chemical and Biomolecular Engineering, Pusan National University, Busan, South Korea. Electronic address:

Monkeypox virus (MPXV) is the causative agent of the monkeypox (Mpox) disease, belongs to the Orthopoxvirus genus of the Poxviridae family. Due to the recent re-emergence of Mpox in 2024, this is the second time when the World Health Organization (WHO) declared Mpox as a Public Health Emergency of International Concern (PHEIC). This review intends to offer an in-depth analysis of Mpox, including its key characteristics, epidemiological, mutation, pathophysiology, transmission, and therapeutics.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!